Recent Comments

    COVID-19 tagged posts

    New research may explain Severe Virus Attacks on the Lungs

    January 1, 2021, Categories  Uncategorized

    The development of human macrophages.
    The development of human macrophages. Illustration: The research team.

    In some cases, immune cells in the lungs can contribute to worsening a virus attack. In a new study, researchers at Karolinska Institutet in Sweden describe how different kinds of macrophages, develop in the lungs and which of them may be behind severe lung diseases. The study, which was published in Immunity, may contribute to future treatments for COVID-19, among other diseases.

    The structure of the lungs exposes them to viruses and bacteria from both the air and the blood. Macrophages are immune cells that, among other things, protect the lungs from such attacks...

    Read More

    Some of the Principal Treatments for Osteoporosis could Reduce the Incidence of COVID-19, study finds

    November 4, 2020, Categories  Biology/Biotechnology, Health/Medical

    Dr. Josep Blanch-Rubió (left) and Jordi Monfort (right). Source: Hospital del Mar.

    Some of the principal treatments for osteoporosis, denosumab, zoledronate and calcium, could have a protective effect against COVID-19 in patients who take them, specifically a 30 to 40% reduction in the rate of infection, according to the results of a joint study by Hospital del Mar, the Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University and the Pere Virgili Health Park. The study, the first of its kind in the world, has just been published the journal Aging.

    The last author of the study, Dr...

    Read More

    Aspirin use Reduces Risk of Death in hospitalized COVID-19 patients

    October 24, 2020, Categories  Biology/Biotechnology, Health/Medical

    University of Maryland School of Medicine
    Jonathan H. Chow , et al. Aspirin Use is Associated with Decreased Mechanical Ventilation, ICU Admission, and In-Hospital Mortality in Hospitalized Patients with COVID-19. Anesthesia & Analgesia, 2020; Publish Ahead of Print DOI: 10.1213/ANE.0000000000005292

    Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM)...

    Read More

    Observed COVID-19 Variability may have underlying molecular sources

    October 22, 2020, Categories  Biology/Biotechnology, Health/Medical

    Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes
    Author links open overlay panel LiangChena
    SikaZhengb

    Study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity. People have different susceptibilities to SARS-CoV-2, the virus behind the COVID-19 pandemic, and develop varying degrees of fever, fatigue, and breathing problems — common symptoms of the illness. What might explain this variation?

    Scientists at the University of California, Riverside, and University of Southern California may have an answer to this mystery.

    In a paper published in Informatics in Medicine Unlocked, the researchers show for the first time that the observed COVID-19 vari...

    Read More